Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PayPal Holdings, Inc. (PYPL) vs Smith & Nephew plc (SNN) Price & Performance

PayPal Holdings, Inc.Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

PayPal Holdings, Inc. vs Smith & Nephew plc — how do they compare? PayPal Holdings, Inc. trades at $55.01 (market cap $47.07B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: PayPal Holdings, Inc. is far larger — about 4.2× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold PayPal Holdings, Inc. for 106 Days and Smith & Nephew plc for 120 Days on average.

PYPLSNN
Market Cap
$47.07B$11.10B
Volume
13,860,0991,051,703
Sector
FinancialsHealth
52-Week High
$75.75$37.17
52-Week Low
$39.08$26.42
Typical Hold Time
106 Days120 Days
Enterprise Value
$49.21B$14.13B
Dividend Yield
1.02%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PayPal Holdings, Inc.

PayPal (PYPL) trades at $54.95, up 0.62% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $56.47. The stock shows strong profitability with a net income margin of 14.36% and ROE of 24.5%, supported by recent earnings beats in Q1 and Q2 2026. A new partnership with Meta's AI agent for checkout services, announced on September 22, 2026, provides a potential growth catalyst amid competitive pressures in digital payments.

PYPL presents a value opportunity with a low P/E of 10.39 and solid cash flow, but faces risks from slowing branded checkout growth and intense fintech competition. The stock's upside hinges on successful execution of Venmo expansion and cost-cutting initiatives under new CEO Enrique Lores, with investor sentiment cautiously optimistic given the 35.71% buy rating from analysts.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue grew to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio, though the stock faces headwinds from analyst downgrades and CFO departure news.

The outlook is cautious; while fundamentals show profitability growth, the stock's proximity to lows and mixed analyst sentiment (26% buy, 65% hold) suggest limited near-term upside. Key risks include competitive pressures and execution challenges, but the stable dividend and institutional interest offer some support for patient investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PYPL
42% Buy58% Sell
Avg holding period · 106 Days
SNN

No sentiment data available yet.

Top news

Latest headlines on both assets

About PayPal Holdings, Inc.

PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.

Read more on PYPL →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →